Inokura
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Inokura, research in cardiovascular disease focuses on conditions such as atherosclerotic cardiovascular disease and elevated Lp(a), with studies designed to assess whether new treatments can reduce major heart-related risks and improve long-term outcomes.
- Evaluating therapies aimed at lowering the risk of major cardiovascular events
- Studying atherosclerotic cardiovascular disease and related risk factors
- Testing whether new approaches can improve prevention and treatment effectiveness
This work reflects a strong interest in helping identify better options for people at increased cardiovascular risk.
Immune System Diseases
The site also supports clinical research in immune system diseases, including eosinophilic esophagitis, where trials are exploring whether new therapies can better control inflammation and improve symptoms for patients.
- Investigating eosinophilic esophagitis and related immune-driven conditions
- Testing treatments that may reduce inflammation and disease burden
- Generating evidence to support more effective care strategies
These studies contribute to a broader effort to improve treatment options for chronic immune-mediated disorders.
Neoplasms
In the area of neoplasms, research at Inokura includes studies in non-small cell lung cancer, with the goal of evaluating new combination treatments and determining whether they can improve survival and disease control.
- Studying non-small cell lung cancer in patients with advanced disease
- Assessing new cancer therapies for better tumor control
- Exploring whether treatment combinations can extend survival
This research supports ongoing efforts to advance cancer care through more effective treatment approaches.
Nervous System Diseases
Clinical trials in nervous system diseases at this pharmaceutical research site include work on narcolepsy and narcolepsy with cataplexy, aiming to improve symptom control and assess how new formulations perform in healthy volunteers and patients.
- Investigating narcolepsy and narcolepsy with cataplexy
- Evaluating treatments intended to improve wakefulness and daily functioning
- Comparing formulations to support better therapeutic use
The research reflects a focus on sleep-related neurological disorders and the development of more practical treatment options.
Virus Diseases
Work in virus diseases includes vaccine research targeting human papilloma virus, with studies designed to examine safety and the body’s immune response to help support prevention of infection-related illness.
- Studying human papilloma virus prevention through vaccine research
- Assessing the potential of new vaccines to strengthen immune protection
- Supporting efforts to prevent virus-related disease
This area highlights the site’s contribution to preventive medicine and infectious disease research.
Behavior and Behavior Mechanisms
Research in psychiatry and psychology at Inokura also covers behavior and behavior mechanisms, including studies in binge eating disorder and acute and chronic pain, with the aim of understanding symptom patterns and evaluating new treatment options.
- Investigating binge eating disorder and acute and chronic pain
- Exploring therapies that may improve symptom management and quality of life
- Generating evidence for better behavioral and pain-related care
These trials show a broad interest in conditions that affect both mental well-being and everyday functioning.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Bioprojet Pharma2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Bioprojet Pharma6trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Inokura
lock Showing 1 of 12 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Bioavailability Study of New Pitolisant Hydrochloride Tablet Formulation Versus Marketed Pitolisant in Healthy Subjects | Bioprojet Pharma | Phase I | Not Recruiting | Apr 2025 | Oct 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 1 | Unknown | 2025-07-08 | 2025-07-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.